Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…

Eli Lilly

Lilly joins drugmakers probed by DOJ about PBMs

Sanofi nabs long-sought FDA approval for daily GLP-1 contender Adlyxin

Changing of the guard at Lilly: CEO Lechleiter to step down at year's end, and SVP Ricks will step up

Fresh off a 9% quarterly sales hike, Lilly sees new launches driving solid growth through 2020

Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth

American Idol star joins Eli Lilly's diabetes kids camp efforts

UPDATED: Lilly, BI narrowly escape with panel backing for Jardiance CV death claim

Lilly's Trulicity joins pay-for-performance trend with Harvard Pilgrim deal

Lilly execs: Net price pressures not a concern for new diabetes meds